phase readout
saveNCT06011733: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis
COMPLETEDupdated 1d ago
community read0 votes
Sponsor: UCB Biopharma SRL. Phase: PHASE3. Conditions: Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis
view source ↗
comments(0)
5-min edit window · permanent after that